An effective and effecient peptide binding prediction approach for a broad set of HLA-DR molecules based on ordered

Proteome Science
|February 26, 2014
PubMed
Abstract

Insights

We developed OWA-PSSM, an improved MHC II binding prediction tool. It accurately identifies peptide ligands and epitopes for 879 HLA-DR molecules, outperforming other methods.

Area of Science:

  • Immunology
  • Computational Biology
  • Bioinformatics

Background:

  • The immune system identifies pathogens via Major Histocompatibility Complex (MHC) II molecules presenting antigenic peptides to CD4+ Helper T cells.
  • Limited experimental data exists for many MHC II alleles due to costly peptide binding measurements.
  • Accurate computational prediction of MHC II peptide binding is crucial for understanding immune responses.

Purpose of the Study:

  • To introduce OWA-PSSM, an advanced computational approach for predicting MHC II molecule peptide binding.
  • To extend the predictive capability for a larger number of MHC II alleles compared to existing methods.

Main Methods:

  • OWA-PSSM is an extension of the TEPITOPE method, enhancing its predictive scope.
  • The approach was evaluated on five benchmark datasets for performance assessment.

Main Results:

  • OWA-PSSM accurately predicts binding cores, outperforming several state-of-the-art methods.
  • It demonstrates comparable performance to TEPITOPE and NetMHCIIpan2.0 for HLA-DR epitopes and ligands.
  • OWA-PSSM significantly outperforms TEPITOPEpan and MultiRTA in specific HLA-DR ligand and T cell epitope identification.

Conclusions:

  • OWA-PSSM provides a fast and robust method for identifying ligands, epitopes, and binding cores for a wide range of MHC II molecules.
  • The approach significantly expands the number of predictable HLA-DR molecules (up to 879).

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.9K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
807
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
10.6K